These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 32259560)

  • 1. Interleukin-6 as a potential biomarker of COVID-19 progression.
    Ulhaq ZS; Soraya GV
    Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
    Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
    Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
    Gao Y; Li T; Han M; Li X; Wu D; Xu Y; Zhu Y; Liu Y; Wang X; Wang L
    J Med Virol; 2020 Jul; 92(7):791-796. PubMed ID: 32181911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Researchers Home in on COVID-19 Severity Biomarkers.
    Abbasi J
    JAMA; 2020 Jul; 324(2):128. PubMed ID: 32662846
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation analysis of the severity and clinical prognosis of 32 cases of patients with COVID-19.
    Ding M; Zhang Q; Li Q; Wu T; Huang YZ
    Respir Med; 2020 Jun; 167():105981. PubMed ID: 32421546
    [No Abstract]   [Full Text] [Related]  

  • 7. Cautious interpretation of antiphospholipid antibodies in COVID-19.
    Mehta S; Bhandari S; Mehta S
    Clin Chim Acta; 2020 Oct; 509():166. PubMed ID: 32553721
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
    Perlini S; Ciprandi G; Castagnoli R; Licari A; Marseglia GL
    Allergy Asthma Proc; 2020 Nov; 41(6):e80-e82. PubMed ID: 33109314
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
    Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
    J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging key laboratory tests for patients with COVID-19.
    Kavsak PA; de Wit K; Worster A
    Clin Biochem; 2020 Jul; 81():13-14. PubMed ID: 32360478
    [No Abstract]   [Full Text] [Related]  

  • 11. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and lung pathology.
    Jain A
    Indian J Pathol Microbiol; 2020; 63(2):171-172. PubMed ID: 32317509
    [No Abstract]   [Full Text] [Related]  

  • 13. Labs scramble to produce new coronavirus diagnostics.
    Cohen J; Kupferschmidt K
    Science; 2020 Feb; 367(6479):727. PubMed ID: 32054740
    [No Abstract]   [Full Text] [Related]  

  • 14. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
    Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
    [No Abstract]   [Full Text] [Related]  

  • 15. The first Vietnamese case of COVID-19 acquired from China.
    Van Cuong L; Giang HTN; Linh LK; Shah J; Van Sy L; Hung TH; Reda A; Truong LN; Tien DX; Huy NT
    Lancet Infect Dis; 2020 Apr; 20(4):408-409. PubMed ID: 32085849
    [No Abstract]   [Full Text] [Related]  

  • 16. Two consecutive myocardial tissue insults for inpatients with COVID-19.
    Su M; Peng J; Wu M; Deng W; Yang Y; Peng YG
    Crit Care; 2020 May; 24(1):259. PubMed ID: 32456648
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2-related atypical thyroiditis.
    Muller I; Cannavaro D; Dazzi D; Covelli D; Mantovani G; Muscatello A; Ferrante E; Orsi E; Resi V; Longari V; Cuzzocrea M; Bandera A; Lazzaroni E; Dolci A; Ceriotti F; Re TE; Gori A; Arosio M; Salvi M
    Lancet Diabetes Endocrinol; 2020 Sep; 8(9):739-741. PubMed ID: 32738929
    [No Abstract]   [Full Text] [Related]  

  • 18. Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: Letter from the warfront….
    Buoro S; Di Marco F; Rizzi M; Fabretti F; Lorini FL; Cesa S; Fagiuoli S
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():8-10. PubMed ID: 32222091
    [No Abstract]   [Full Text] [Related]  

  • 19. Real-time RT-PCR in COVID-19 detection: issues affecting the results.
    Tahamtan A; Ardebili A
    Expert Rev Mol Diagn; 2020 May; 20(5):453-454. PubMed ID: 32297805
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac Troponin I Is an Independent Predictor for Mortality in Hospitalized Patients With COVID-19.
    Nie SF; Yu M; Xie T; Yang F; Wang HB; Wang ZH; Li M; Gao XL; Lv BJ; Wang SJ; Zhang XB; He SL; Qiu ZH; Liao YH; Zhou ZH; Cheng X
    Circulation; 2020 Aug; 142(6):608-610. PubMed ID: 32539541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.